Check into your stock benefits, including when
the current stock purchasing cycle end.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the
purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and
purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign
current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated
stock repurchase plan, among other things.
It might be worth it to stick around at your
current job for a few extra days or weeks so that you're eligible to
purchase more
stock.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP
purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and
current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its
stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
(a) Schedule 2.7 (a) of the Disclosure Schedule contains a list setting forth each employee benefit plan, program, policy or arrangement (including any «employee benefit plan» as defined in Section 3 (3) of the Employee Retirement Income Security Act of 1974, as amended («ERISA»)(«ERISA Plan»)-RRB-, including, without limitation, employee pension benefit plans, as defined in Section 3 (2) of ERISA, multi-employer plans, as defined in Section 3 (37) of ERISA, employee welfare benefit plans, as defined in Section 3 (1) of ERISA, deferred compensation plans,
stock option plans, bonus plans,
stock purchase plans, fringe benefit plans, life, hospitalization, disability and other insurance plans, severance or termination pay plans and policies, sick pay plans and vacation plans or arrangements, whether or not an ERISA Plan (including any funding mechanism therefore now in effect or required in the future as a result of the transactions contemplated by this Agreement or otherwise), whether formal or informal, oral or written, under which (i) any
current or former employee, director or individual consultant of the Company (collectively, the «Company Employees») has any present or future right to benefits and which are contributed to, sponsored by or maintained by the Company or (ii) the Company or any ERISA Affiliate (as hereinafter defined) has had, has or may have any actual or contingent present or future liability or obligation.
Dividend Reinvestment Plans (DRIPs) are programs which allow
current shareholders to
purchase stock directly from the company, bypassing the broker and brokerage commissions.
But given the actual market conditions which remain in place, it's difficult to imagine just what investors are hoping for - and what they think their money is actually buying - when they
purchase stocks at
current prices.
Let's say you own
stock with a
current value of $ 55,000, which you
purchased for $ 5,000.
First, the
stocks I currently own that I consider would like to
purchase more of at
current market prices.
In his
current role, Josh manages shareholder services for publicly traded and private companies out of AST's San Francisco Bay Area office where he assists with planning, developing and administering a wide range of services, including
stock splits, acquisitions involving both stock and cash exchanges, corporate spin - offs, implementing and administering Direct Stock Purchase Plans, assisting clients with DRS, full dematerialization programs and shareholder information and communication campa
stock splits, acquisitions involving both
stock and cash exchanges, corporate spin - offs, implementing and administering Direct Stock Purchase Plans, assisting clients with DRS, full dematerialization programs and shareholder information and communication campa
stock and cash exchanges, corporate spin - offs, implementing and administering Direct
Stock Purchase Plans, assisting clients with DRS, full dematerialization programs and shareholder information and communication campa
Stock Purchase Plans, assisting clients with DRS, full dematerialization programs and shareholder information and communication campaigns.
Options can help you protect against risk, generate income, increase profits, lower your breakeven point, reverse your strategy without selling your
stock, and even potentially let you set a
purchase price for a
stock below its
current market price.
This isn't to say that
stocks can't deliver adequate returns between now and some narrow set of future dates, but to expect that
stocks purchased at these levels will deliver attractive long - term returns in general requires the assumption that
current valuations will remain elevated into the indefinite future.
In other words, if a very long - term investor is willing to rely on the notion that valuations when they sell will match or exceed the unusually high valuations of the present, that investor can reasonably expect
stocks purchased at
current levels to deliver long - term returns somewhere the range of 8 - 10 %.
To do this, I run my
current holdings and potential
stock purchases through what I call the Dividend Deep Dive.
If you couldn't find a margin of safety in the
current stock market, you might own gold because you believe gold relative to dollars is safer, holds
purchasing power better, more stable, etc..
Therefore, investors who have faith in the management and believe that the ongoing transformation will bear fruit should consider
purchasing the
stock at its
current level.
Pgm # 36236: $ 500.00 Bonus Cash for
current college students and recent college graduates who
purchase or lease any eligible new vehicle and take retail delivery from dealer
stock by 01/02/2019.
My
current truck they change over the tires from
stock to the ones I
purchased and threw in a bed cover for free.
To receive or verify
current product information, please contact the dealership All units are subject to prior sale and just because it is posted for sale online does not guarantee it is in
stock or available for
purchase.
That means libraries are going to become even less relevant to patrons who are already leaving in droves, as they won't
stock current bestsellers, knowing that their meager budgets can be spared if they wait to make new book
purchases.
We will
purchase the
stock only when its
current market price represents a discount to our valuation.
I also decided that I wanted to handle my own investing online using a discount brokerage firm so I starting looking at my options: My
current online brokerage account (I had
purchased Air Canada
stock about 6 months before bankruptcy, but that story is for another time) was an option, but they charged $ 29 / trade and an annual RRSP account fee ($ 50 / year).
If a portfolio
stock becomes the object of a takeover or merger that closes before the one year anniversary of its
purchase, reinvest in the
current QS as soon as the cash is received and / or any securities received in exchange are sold.
Discounts: In addition to no - fee dividend reinvestment, some companies also offer DRIPs that allow investors to
purchase stock at a discount to the
current market price.
For
stocks and ETFs you'll incur two commissions plus a hidden cost called the bid - ask spread on the extra sale and
purchase you'll make when using the
current sale strategy.
However, if you are a patient dividend investor and hold the
stock for a while, your cost of
purchase dividend yield will be much higher than the
current dividend yield.
Whether an in the money strike price is higher or lower than the
current stock value depends on the type of option contract
purchased.
As for how long I have been holding my dividend
stocks, here are my
current stocks and when I made my most recent
purchase of them.
When a
stock is held for a few months, until it pays dividends to the investor for the first time, investor's total return can be calculated straightforwardly, just by adding up the
current value of the securities held (prices multiplied by
stock held) and the dividends earned, dividing that result by the cost of
purchase if we want to obtain a rate, and multiplying that result by 100 if we want it expressed as a percentage.
The intrinsic value is simply the amount by which the
stock's
current price is higher than the call strike - it's the
current discount to the
stock's price that you get if you exercise the call, thereby
purchasing the
stock at the strike price.
This means he must
purchase the
stock at the
current market price of $ 45.
The ideal form of common
stock analysis leads to a valuation of the issue which can be compared with the
current price to determine whether or not the security is an attractive
purchase.
If the
current price of a given
stock is $ 20, for example, a dividend payment of $ 30 would
purchase 1.5 additional shares.
DRIPs are programs which allow
current shareholders to
purchase stock directly from the company, bypassing the broker and brokerage commissions.
The early 1970s was the era of the «Nifty Fifty,» in which the prevalent investing philosophy was that the only
stocks that should ever be
purchased — and
purchased regardless of their
current prices — were the 50 biggest growth
stocks in the world.
Like ETF and listed
stock orders, NextShares orders transmitted by broker - dealers to Nasdaq are matched against the best
current offer (for a
purchase) or best
current bid (for a sale) for execution.
The other way to calculate a
stock dividend yield is by using the very same formula (Dividend payout /
stock price) but using the
current dividend payout divided by the
stock cost of
purchase value.
Investors who
purchase growth
stocks receive returns from future capital appreciation (the difference between the amount paid for a
stock and its
current value), rather than dividends.
Although it feels good to be closing in on a portfolio value of $ 150,000, I'd much prefer a natural correction in the
stock market which would allow my
current capital (which is more limited than usual) to go further by being able to
purchase cheaper equities with higher yields.
I use the
current dividend when I'm about to
purchase a
stock.
The first thing we think about when we buy a
stock is if we'd be happy
purchasing the whole company at the
current price and holding it for a long time.
Automatic or not, the investor is making a choice to
purchase shares of a
stock at the
current price, yield, etc, and therefore it should be treated as a
purchase.
My first, more limited, technique confines itself to the
purchase of common
stocks at less than their working - capital value, or net -
current asset value, giving no weight to the plant and other fixed assets, and deducting all liabilities in full from the
current assets.
This still requires you to
purchase the
stock outright, but then instantly after
purchase you have doubled your investment (if
purchased at 50 % the
current market value).
Once done, you will be displayed a list of all the financial assets you have transacted on the
stock market with their
purchase value,
current market value, your overall profit / loss.
You should take advantage of signals to
purchase the
stock, be able to ride the
current price momentum for a specific period of time, and then sell your
stock for fast cash.
To do this, I run my
current holdings and potential
stock purchases through what I call the Dividend Deep Dive.
As a newbie, I still spend a lot of time researching, and in a couple of blogs I have seen references to companies that will provide a small discount on the
current stock price when
purchasing additional shares using their DRIP program.
For example, say I built a $ 200k
stock portfolio that had an average yield of 5 % (easy at
current prices, even with blue chips), and then
purchased a $ 200k rental property with cash that yielded 7.5 % after all costs (easy to do in the US right now, but also possible in certain Canadian cities like Hamilton or Kitchener).
It may change the way you think about your
current portfolio and your future
stock purchases.